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1.  Abstracts 
 
1.1.  English 
Porcine Circovirus Type 2 (PCV2) is the obligate infectious agent in Postweaning 
Multisystemic Wasting Syndrome (PMWS) of pigs. We vaccinated dams twice before 
and once during pregnancy with an inactivated PCV2 vaccine and monitored health 
status, antibody titers in dams and piglets and growth parameters of their progeny. Two 
producer farms, run under the supervision of the Swiss Swine Health Organisation and 
categorized in the highest health status, were selected for the study. Historically, PMWS 
was diagnosed in animals of one farm at the weaning stage, whereas in the other farm, 
pigs wasted during the fattening period. Groups of dams in each farm were randomly 
chosen for vaccination or sham injection.  
Compared to historical data, cases of PMWS decreased 4-12-fold among all animals of 
both farms. In sera of vaccinated dams only low concentration of PCV2 DNA was 
detected and no case of PMWS was diagnosed in their progeny. Vaccination increased 
serum antibodies of dams significantly accompanied with significant increased colostral 
antibody titers in their offspring. However, after weaning, progeny from vaccinated dams 
showed a significant increased daily weight gain and shortened fattening period 
compared to controls. This is the first demonstration of an effect of subclinical circovirus 
infection on growth performance of fattening pigs that can be controlled by vaccination 






1.2.  German 
Porcine Circovirus Typ 2 ist der notwendige Erreger beim Multisystemic Wasting 
Syndrom (PMWS) beim Schwein. In unserem Versuch wurden Mutterschweine zweimal 
mit inaktiviertem PCV2 Impfstoff vor und einmal während der Trächtigkeit geimpft. Von 
Muttersauen und Nachkommen wurden Daten zum Gesundheitsstatus, 
Antikörperverlauf und Mastleistungen erhoben. Für den Feldversuch wurden zwei SDG 
Zuchtbetriebe mit dem höchsten Gesundheitszustand ausgewählt. Während PMWS 
beim einen Betrieb früher während der Absetzphase aufgetreten ist, traten beim 
anderen Betrieb Probleme mit PMWS erst während der Mastperiode auf. Im Versuch 
wurden die Muttersauen in beiden Betrieben zufällig in eine Impf- bzw. Placebogruppe 
eingeteilt. Im Vergleich zu früher haben die PMWS-Fälle auf beiden Betrieben um das 4-
12fache abgenommen. In Seren von geimpften Muttertieren konnte PCV2-DNA nur 
niedriger Menge nachgewiesen werden. PMWS Fälle traten nur noch bei den 
Nachkommen von ungeimpften Kontrollsauen auf. Die Impfung gegen PCV2 erzeugte 
eine signifikante Erhöhung der Serumantikörpertiter bei den Muttertieren bzw. der 
Kolostralantikörpertiter bei deren Ferkel. Im Vergleich zur Kontrollgruppe wiesen 
Nachkommen geimpfter Muttertiere eine erhöhte Masttageszunahme und eine verkürzte 
Mastdauer auf. Erstmals konnte die Wirkung einer Mutterschutzimpfung auf das 







2.  Introduction 
PMWS in pigs was first described in Canada [1] and has since been recognized as one 
of the economically most important swine diseases worldwide [2-8]. PMWS emerged as 
an epizootic disease in Switzerland in 2003/2004 even though most pig farms were kept 
under specific pathogen free animal conditions monitored by the Swiss Swine Health 
Organisation [9]. 
PMWS is an acute or chronic disease in animals around the age of 5-16 weeks [10, 11], 
or exceptionally to 30 weeks [12]. Typical signs are wasting, profuse diarrhoea, 
dyspnoea and pigs may have gastric ulcers, enlarged lymph nodes, anaemia, icterus, 
haemorrhages, dermatitis, nephropathy, vasculitis or edema in various organs [1, 11, 
13-15]. 
Various PCV2 genotypes are considered to be the main aetiological agent of PMWS [3-
7, 14, 16]. Nevertheless, PCV2 can be detected in healthy pigs or isolated from various 
cells and organs including peripheral blood, mononuclear cells, dendritic cells, 
lymphocytes, and viral antigen is often found in defined lymphatic areas in lymph nodes, 
tonsils, spleen, and thymus or is scattered in their supporting reticular cells associated 
with irregular tissue architecture and in macrophages [14, 17]. In other cases, PCV2 was 
diagnosed in lung, liver, kidney and gastro intestinal tract and in rare cases in apoptotic 
vascular endothelial cells of the brain [18]. 
As PCV2 can replicate in multiple cells of various organs to measurable titers in clinically 
healthy or diseased animals, the virus may be present in sera or all other body fluids [11, 
13] including semen [19, 20]. Infection of naïve animals may occur by direct contact with 
infected animals, their secretions or air borne dissemination is considered due to high 
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viral loads in large farms [21]. In addition, natural vertical transmission was diagnosed in 
field cases [22, 23] or could be induced experimentally [24, 25]. Experimentally infected 
dams delivered dead and stillborn piglets. PCV2 infection in fetuses was verified and 
was associated with myocarditis, fibrosis and degeneration of the myocardium as well as 
depletion of lymphocytes [26, 27]. Recent evidence further suggests that intrauterine 
infection may have been underestimated at least in some herds [28].  
In a retrospective epidemiological study PCV2 could be traced back to 1979 in 
Switzerland [9]. Nevertheless, it was not until 2001 when the first clinical PMWS case 
was confirmed [29]. However, the epizooty started in the late 2003 in areas with high 
swine populations [30].  
Since, PCV2 is endemic and can be isolated from PMWS diseased and clinically healthy 
animals. PCV2-specific antibodies are detected in almost all pigs [11, 31-35]. Another 
complicating factor is the observation that the profiles of PCV2 serum antibody titers of 
pigs from PMWS affected and unaffected herds are almost identically [36, 37]. Thus, the 
presence of PCV2 specific IgG antibodies are of limited diagnostic or prognostic value 
and should be considered for diagnostics in conjunction with disease pattern and PCV2 
viral load [38]. 
Until recently, the main focus in reducing PMWS was the optimization of herd 
management in general [39, 40] and intensifying the survey of health program such as 
those run by the Swiss Swine Health Organisation (www.suisag.ch/SGD/Richtlinien). 
Despite the absence of Porcine Reproductive and Respiratory Syndrome (PRRS),  
Enzootic Pneumonia (EP), Actinobazillosis (APP), progressive Atrophic Rhinitis (pRA) in 
Switzerland, PMWS occurred in such herds [9]. Hence, other measures had to be taken 
to control the disease. Vaccination against PCV2 was thus considered. 
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Two types of vaccines against PCV2 were introduced in Europe. One is used to 
vaccinate pregnant sows to increase colostral antibody concentration and the other is 
used to vaccinate piglets. Several field studies have demonstrated that vaccination of 
nursing piglets is effective in reducing losses caused by PMWS and that maternal 
antibodies present at the time of vaccination did not interfere with active antibody 
production [41-43].  
In the present study, pregnant sows from two different farms under the control of the 
Swiss Swine Health Organisation with a PMWS history were immunized. The ubiquitous 
presence of PCV2 may facilitate intrauterine or perinatal infection [44]. Vaccination of 
pregnant dams against PCV2 may decrease overall viral load perinatally and increased 
colostral antibodies may protect offspring within the first day of life. To test the 
effectiveness of vaccination reproductive parameters, antibody production of the dams 
and antibody transfer to piglets, mortality rate, growth performance of offspring and age 
of slaughter were analyzed.  
 
3.  Materials and Methods 
 
3.1  History of the herds 
This study took 15 months. We used Circovac® (Merial SA, Lyon) in two different farms 
with a history of recurrent PMWS. In both herds PMWS has been diagnosed before the 
start of the study using criteria defined by Sorden [38] and used as described by 
Wiederkehr et al [9]. 
Both herds were on a health program run by the Swiss Swine Health Organisation and 
were categorised in the highest health category and declared free of PMWS cofactors as 
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Porcine Reproductive and Respiratory Syndrome (PRRS), Enzootic Pneumonia (EP), 
Actinobazillosis (APP), progressive Atrophic Rhinitis (pRA) and mange. In both farms 
the piglet were weaned at the age of 4-5 weeks of life. 
Herd X was a breeding herd with 90 Swiss Large White sows. Gilts were raised for 
replacements within the farm. Piglets were sold to a regional finisher at the age of 
approximately 10 weeks at a body weight of 22-27 kg. Only sporadic cases of PMWS 
had occurred in herd X since 2006, but there had been considerable losses in the 
finishing operations. 10-15% of these pigs developed PMWS as verified by pathological 
examination.  
Herd Y was a breeding herd with 150 Swiss Large White x Landrace crossbred sows. 
Gilts were purchased from another farm and added to this herd without quarantine. 1-2 
weeks after weaning approximately 5-20% of the weaned pigs had low daily weight gain 
and profuse untreatable diarrhoea with a herd mortality rate of 5-10%, indicators of a 
serious PMWS problem confirmed by laboratory diagnostics. 
 
3.2. Vaccination protocol 
Sows were randomly chosen for either vaccination or were injected with adjuvant as a 
control group. The inactivated PCV2 vaccine Circovac® (Merial SA, Lyon) was used at a 
dose of 2 ml administered deep into the neck musculature, using a 1.2x40 mm needle, 
four and two weeks before artificial insemination and four weeks ante partum. One 2 ml-
dose contained ≥2.1 log10 PCV2 antigenic units, 0.2 mg thiomersal and 500 mg paraffin 
as an adjuvant.  
Furthermore for some comparisons, the dams were categorised as young (≤3 litters, 
n=65) or experienced dams (>3 litters, n=159) as indicated in the data sets.  
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3.3  Blood collection for serum production 
10 ml blood was collected from the jugular vein of dams immediately before the first 
injection (B0), four weeks after the second injection (B1) and two weeks after the third 
injection (B2). 2-5 ml blood was collected from 100 individually tagged piglets at the age 
of 3, 10, 31, 42, 56, 63 days post partum (pp). This study was carried out according 
Swiss Animal Welfare guidelines (study number 06/07). 
 
3.4  Serological examinations 
A competitive ELISA (SERELISA® PCV2 Ab Mono Blocking Systems (Synbiotics 
Corporation Europe SAS, Lyon) was used for antibody (IgG) detection [45]. The 
completion of the test, data analysis and transformation of the data into ELISA units 
were done according to the manufacturer’s instructions and a published reference [45]. 
We supplemented the assay with two additional controls to the sera dilutions suggested 
by the manufacturer. Firstly, we used an additional positive and negative control serum 
to check plate antigen coating homogeneity. Secondly, we normalized S-values among 
individual plates with the aid of a known serum. 
Immunoglobulin M (IgM) was measured using INGEZIM CIRCOVIRUS IgG/IgM 
(Ingenasa, Madrid) a capture immunoenzymatic assay specific IgM antibody detection to 
PCV2.  
 
3.5 Production variables of sows 
Parity number, litter weight, number of live and dead born piglets, number of mummies, 
number of piglets weighing below 1 kg, the number of piglets lost during the nursing 
period and the cause of death were recorded for each dam. 
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3.6 Production variables of progeny 
Cross-fostered piglets from large to small litters were not considered in this study. The 
variables Average Daily Weight Gain (ADWG1) is generated as live slaughter weight (kg) 
divided per age in days.  ADWG2 is generated as live slaughter weight (kg) minus weight 
at the beginning of the finishing period (kg) divided per number of finishing days. The 
carcass weight was considered to represent 78% of the live weight at slaughter and was 
used to calculate the latter. The number of finishing days was calculated from the dates 
of slaughter and weaning. 
 
3.7 Pathological examinations 
All mummies, stillborn and dead nursing piglets as well as the dead weaning and 
fattening pigs, were examined at the Institute of Veterinary Pathology, Vetsuisse Faculty 
of Zurich. If deemed necessary, histological, bacteriological and virological examinations 
were also inducted. When PMWS was suspected, tissues were examined 
immunohistochemically  (IHC) and with PCR for PCV2 infection [9, 46, 47]. 
 
3.8 Statistics 
Statistical calculations were carried out using StatView 5.1 (SAS Corporation). ANOVA 
for repeated measures, unpaired and paired t-tests were considered statistically 





4.  Results  
 
4.1  Occurrence of PMWS during the vaccination period 
This study was conducted within a period of 15 month. During this time, 379 dead piglets 
of a total of 2720 (13.9%) born piglets occurred and underwent a post mortem 
examination. 176 were from herd X and 203 from herd Y. This number includes aborted, 
stillborn piglets and perinatal losses. The majority of the piglets were crushed by their 
mothers during the first week of life. There were no significant differences in the number 
of piglets lost between the vaccinated and non-vaccinated dams in both herds. 60 of the 
dead piglets were examined immunohistochemically for the presence of PCV2 antigen. 
All were negative.  
At the weaning stage, 9 of 1169 weaned pigs died in herd X (0.8%) and 15 of 1172 in 
herd Y (1.3%). PMWS was diagnosed in none of these pigs. 
During the fattening period a total of 423 pigs were monitored until slaughter (112 of 
herd X and 311 of herd Y). PMWS was diagnosed in 2 of the 112 pigs born to two non-
vaccinated sows of herd X (1.8%). Interestingly, no case of PMWS was diagnosed in 
311 fattening pigs from herd Y. 
Compared to the historical data the mortality rate at the weaning stage of herd Y 
dropped from an average of 8.7% to 1.3% and in the finisher of herd X from 10-15 % to 
1.8%. Vaccination may have had an effect on the overall health status of vaccinated and 
control animals by reducing viral pressure in general and in the antibody production in 








At the start of the experiment (time B0), 99% of all dams had antibodies against PCV2. 
In herd X, the mean titer at B0 of all sows was significantly (p=0.006) higher than that of 
herd Y (Fig. 1; Table 1). At time points B1 and B2, vaccinated dams of both herds had 
significantly higher titers against PCV2 than unvaccinated dams. In the vaccinated ones 
there were significant differences in serum titers between B0 and B1 in both herds. 
Titers increased up to nine-fold compared to the titres at B0. 
We noted a fluctuation in titers over time in the unvaccinated dams that may have been 
due to subclinical infections. The dams of herd Y had a lower titre at time point B0 than 
herd X, (Table 1). The unvaccinated controls showed a mild but significant increase in 
titer (herd X, p=0.03; herd Y, p=0.04) between time points B0 and B1, but no significant 
difference between B1 and B2. Only low concentrations of PCV2 DNA (<5x105 Copies 
/ml) were detected by PCR in some sera (data not shown). 
* p≤0.05 
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A closer analysis of titers between young and experienced dams revealed some 
interesting observations (Table 1). Young dams had a 3.5-fold higher baseline titer (B0) 
than experienced dams (p<0.0001). At B1, vaccinated young dams had the highest titer 
(6820 EU) measured during the entire study.  
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Table 1.  Antibody titers of dams in Farm X and Y, young and experienced dams  
and piglets 
 
A: Antibody titers (ELISA Units) of all dams in herd X and Y 
 
 herd X herd Y 
Time vaccinated  unvaccinated p-value vaccinated unvaccinated p-value 
 (n=46) (n=68)   (n=67)  (n=43) 
 
B0 1613±306 1893±369 >0.05 887±157 1046±278 >0.05 
B1 5035±410 2140±339 <0.05 6303±487 1508±345 <0.05 
B2 5156±358 1670±344 <0.05 5661±358 1140±193 <0.05 
 
B: Antibody titers in young and experienced sows   
 
 young dams experienced dams 
Time vaccinated unvaccinated p-value vaccinated unvaccinated p-value 
 (n=42) (n=24)  (n=71) (n=88) 
 
B0 2229±781 2229±331 >0.05  874±173     564±105 >0.05 
B1 6820±511 3255±929 <0.05 5176±431 1360±184 <0.05 
B2 6404±475 2068±531 <0.05 4895±422 1157±193 <0.05 
 
C: Antibody titers in piglets from vaccinated or unvaccinated dams of herd Y 
 
Time pp. vaccinated (n=53)  unvaccinated (n=48)  p-value 
 
03  5173±322   2323±308   <0.05 
10  4319±248   1266±203   <0.05 
31  3062±359   1037±206   <0.05 
42  1943±296     279±69   <0.05 
63    511±81       86±31   <0.05 
 
B0 (before 1th vaccination), B1 (four weeks after second injection), B2 (two weeks after third injection) with 
mean antibody titer and standard deviation. 
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Figure 2. Antibody titers in piglets 
 
 
4.2 Antibody titers in piglets 
For these experiments sera from 101 offspring of vaccinated and unvaccinated dams 
were collected in herd Y. At all times, the piglets from vaccinated dams had significantly 
higher PCV2 antibody titers than piglets from unvaccinated dams (p<0.001; Table I; Fig. 
2). From day 3 post partum (pp) to 63 pp, the antibody titer in the vaccinated group 
decreased gradually from 5173 EU to 511 EU. In the piglets from the unvaccinated 
ones, the antibody level decreased from 2323 EU at day 3 pp to 86 EU at day 63 pp. 
The decrease was gradually until day 63 pp with a drop at day 31 pp. At no time point a 
significant seroconversion was noted as previously described [42]. This is paralleled by 
the absence of any case of PMWS at this stage. 
To detect potential subclinical infections, the sera of all piglets from unvaccinated and 
vaccinated dams collected at day 10, 31, 42, 56 and 63 were examined for IgM antibody 
against PCV2. Four piglets from unvaccinated sows in herd Y were positive at day 56 




4.3 Offspring production parameters 
Offspring of vaccinated dams from both herds X and Y had significantly greater daily 
weight gains from birth to slaughter compared with the controls of unvaccinated dams 
(Table 2). The difference of ADWG1 between progeny from vaccinated and 
unvaccinated dams in herd X was 33 g/d and in herd Y 20 g/d. From weaning to 
slaughter the difference between offspring of vaccinated and unvaccinated dams was 51 
g/d in farm X and 30 g/d in farm Y. The age at slaughter of pigs from the vaccinated 
ones was reduced in herd X by 6.7 days (p=0.03) and by 5.5 days in herd Y (p=0.02). 
Therefore, the increased antibody titer in dams, transmitted by colostrum was 
associated with a significant impact on health status of the offspring reflected by 
increased weight gain.  
 
Table 2. Growth performance of progeny 
Production parameters of offspring from vaccinated and unvaccinated dams in farm X 
and Y 
 
progeny farm X (n=112)    progeny farm Y (n=311) 
 
   vaccinated  unvaccinated p-value vaccinated unvaccinated p-value 
   (n=57)           (n=55)                              (n=182)         (n=119) 
 
ADWG1 (g/d) 626±0.01 593±0.01 <0.05 585±0.01 565±0.01 <0.05 
 
ADWG2 (g/d)  785±0.02 734±0.02 <0.05 726±0.01 696±0.01 <0.05 
 




5.  Discussion 
Dam vaccination was associated with a stunning improvement of the health status of 
offspring at the weaning stage and especially of the fattening period. Moreover, offspring 
of vaccinated dams outperformed pigs from unvaccinated dams in weight gain and 
decreased time to reach maturity for slaughter. We associated these economic benefits 
with low PCV2 viral pressure, due to vaccination of dams and their transfer of colostral 
antibodies to progeny in particular. 
Historically and during the experiment none of the two farms selected for our 
experiments had cases of reproductive disorders due to PCV2 according to the records 
of the Swiss Swine Health Organization (unpublished data). Furthermore, all of the sera 
collected from adult animals had low concentration of PCV2 DNA (<5x105 copies/ml). 
The perinatal loss of some 14% was not affected by vaccination and is in the range of 
small to mid-sized pig farms surveyed by the Swiss Swine Health Organization 
(Geschäftsbericht SUISAG; Zahlen und Projekte 2010). Therefore, the existing natural 
immune responses of the dams against PCV2 enhanced by vaccinating dams appeared 
sufficient to prevent fatal intrauterine infection.   
During the experiment, we did not find any indication of PCV2 associated diseases in 
the 379 analyzed dead pigs. By contrast, the historical loss of 5-10% of pigs after 
weaning or in the early fattening period respectively was improved 6-12 fold during the 
experiment. Only 2 of the 423 evaluated fattening pigs (1.3%) died of PMWS during the 
experiment in the early finishing period. Interestingly, the two pigs were born to 
unvaccinated dams. Therefore we suggested that vaccination significantly improved the 
health status of all offspring irrespectively of the vaccination status of the dams and 
might indeed be due to an overall lowered infectious pressure of PCV2.   
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As expected from previous epidemiological and serological examinations all dams had 
antibodies from natural exposure to PCV2 before vaccination [21, 37]. In contrast to 
other reports [41, 48] we opted to vaccinate twice before and once during pregnancy to 
compensate for a potential loss of serum antibodies into the colostrum [49]. Vaccination 
boosted antibody titers 3-9 fold after one vaccination that leveled off or decreased after 
the second immunization. This phenomenon was observed in the unvaccinated dams, 
bled at the same time, as well.  
The PCV2 specific antibody titer in the sera from piglets of vaccinated dams was very 
similar to those of their mothers as previously described [49]. The antibody titer in these 
piglets decreased gradually about 10 fold within 60 days and was in average 6 times 
higher than that of the controls at the same time point. Antibody titers against PVC2 in 
neonatal piglets of unvaccinated dams also reflected that of their mothers in the first few 
days of life [49], but the decrease of the mean titer in these animals until day 63 was 30 
fold. The antibody titers of progeny from vaccinated dams was in the 6th week of life 
about the same as the titer of the controls at third day of life. In addition, the decrease of 
the titer was not gradual but had a sharp drop after day 31. We suspected subclinical 
PCV2 infection in those pigs. Thus, we tested the presence of IgM antibodies isotype 
specific to PCV2 and attempted to PCR amplify viral DNA. Notably, four of 53 pigs of the 
unvaccinated group developed IgM antibodies at the age of 56 days pp against PCV2 
but none of the vaccinated group. Nevertheless, we could not detect PCV2-DNA in 
blood of these piglets (data not shown). Based on the observed IgM antibodies we 
concluded that these four piglets were newly subclinically infected with PCV2 as 
antibodies of this isotype were not detected at earlier time points (data not shown). 
 18 
The improvements in the general health status of pigs from vaccinated dams were 
further observed in the significant higher daily weight gain and decreased time to 
slaughter when compared to offspring from unvaccinated dams. It is tempting to 
speculate that the improved immune status of vaccinated dams and the increased 
colostral antibodies taken up by their offspring decreased the overall infectious pressure. 
Indeed, before the vaccination experiments the antibody titres of sows in both farms was 
generally lower.  
Although a direct comparison of results in an industrial setting is difficult. Vaccination of 
dams, as done here, rather than 2-3-weeks old piglets [42, 50, 51]  might have some 
advantages. Perinatal virus load of gilts or piglets may have been underestimated at 
least in some herds [28, 52]. PCV2 can infect a variety of cells and replicates 
preferentially in dividing cells [17]. Dividing cells are very important to reach adult stage 
cell numbers and are crucial for the development of the architecture of organs of the 
immune system, the gastro intestinal tract and the central nervous system. Failure or 
delayed maturation of the immune system may favour secondary infections or growth 
retardation due to inadequate food intake or inadequate hormonal regulation of body 
growth [53].  
It is very difficult to induce a protective immune response right after birth in mammals. 
Therefore, piglets are generally vaccinated at three to four weeks of age. During this 
time the animals are protected by maternal antibodies that may vary depending on the 
immune status of the dam and thus, piglets will be exposed to the PCV2 viral pressure 
present in the herd with potentially devastating effects. The vaccination of dams 
appeared to decrease the infective pressure generally and provided increased 
antibodies against PCV2 in colostrum to protect the piglets within the first days of life. At 
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this age, colostral antibody is the only specific immune mediator available to the piglets 
before they can generate their own.  
This is the first evidence of a subclinical infection of PCV2 as determined by the daily 
weight increase of pigs during the fattening period. We consider weight gain of young 
animals as a mirror to reflect a combined effect of the virus on rapidly dividing cells 
necessary in the development of the immune-, hormonal- and nervous system 
influenced by the gastrointestinal or respiratory tract. The IgM antibodies specific to 
PCV2 not present in colostrum but determined in sera of unvaccinated piglets at 56 days 
of age indicate a perinatal infection even though viral DNA was not detected. 
Therefore, in the absence of overt PCV2 associated diseases, small amounts of PCV2 
might interfere with the maturation of newborn individuals possibly by interfering with 
rapidly diving cells. Circoviruses are extremely widespread, prone to genetic alterations 
and may adapt to different species [54]. The recent identification of circoviruses in stool 
samples of very young children should be considered in the light of our data. A similar 
spread as in other species should be monitored and immune responses analysed. 
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